BGI Research
Includes BGI Research - Shenzhen, Qingdao, and Sanya, and is equipped with extensive DNA sequencing, bioinformatics and AI capabilities for exploring restricted deep-sea and global marine resources. These capabilities enable groundbreaking research into marine biodiversity and the discovery of bioactive compounds with ecological significance, and potential therapeutic and industrial applications.
MGI
Offers advanced fabrication, manufacturing, sequencing, and AI technologies, driving innovation in genomics and synthetic biology. With access to cutting-edge equipment and comprehensive support, MGI empowers researchers to transform scientific discoveries into market-ready products.
BGI Nutri
Offers a robust commercialisation platform designed to accelerate the translation of scientific and technological breakthroughs in nutraceuticals into market-ready products, while fostering collaboration between researchers, industry partners, and consumers, to drive advancements in health and wellness.
NEOPRIMARIES
Houses state-of-the-art synthetic biology platforms, facilitating the synthesis of bioactive molecules, and paving the way for the scale-up manufacturing of novel therapeutics and functional ingredients. The integration of advanced synthetic biology techniques ensures the sustainable and efficient production of these valuable compounds.
